MedWatch

Almirall partner MC2 on the verge of EU victory after ten years of hard work

The fact that MC2 therapeutics is close to its EU and US launch for the psoriasis treatment Wynzora is a significant milestone, says CEO Jesper Lange.

Photo: MC2 Therapeutics / PR

On Tuesday, MC2 Therapeutics and its partner Almirall announced that they had completed the EU decentralized procedure for the psoriasis treatment Wynzora, which is the last step before individual the health authorities in individual European countries can start issuing marketing authorizations.

For MC2, which developed Wynzora, the fact that the drug is on the brink of being launched in the EU and the US is the culmination of many years of work. It was approved in the US last year.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Coloplast upgrades growth expectations following acquisition

Medtech firm Coloplast’s Q1 report for 2021/2022 brings a slight upward adjustment of the reported revenue growth outlook due to foreign exchange developments. Coloplast’s acquisition of Atos Medical is expected to contribute around 6 percent to organic growth.

Demant's surgical division loses president of 13 years

Oticon Medical, the implants division at hearing group Demant, is saying goodbye to President Jes Olsen, who is exiting his role in March after having spearheaded the business leg since 2008. Demant CEO Søren Nielsen is stepping in temporarily until a replacement is found.

Hearing aid market in US grew by 37 percent in 2021

Hearing aid manufacturers have had a good year following one of the worst in their recorded history, as sales in the US have gone up by 37 percent. The progress is mainly driven by the recovery of independent retailers, whereas public sales channel Veterans Affairs still lags behind.

Further reading

Related articles

Latest news

See all jobs